Franklin Schneier, M.D.
Research Psychiatrist, Clinical Therapeutics,
New York State Psychiatric Institute
Dr. Franklin Schneier is a Special Lecturer at Columbia University College of Physicians and Surgeons and Research Psychiatrist in the Anxiety Disorders Clinic at New York State Psychiatric Institute. Dr. Schneier is a graduate of Yale College and Cornell University Medical College, and he completed his residency in psychiatry at Mt. Sinai Medical Center. He came to the Anxiety Disorders Clinic in 1987 as a research fellow, later serving as associate director of the clinic and currently as a research psychiatrist. He is a member of the Scientific Advisory Board of the Anxiety Disorders Association of America.
Dr. Schneierï¿½s research has focused on the diagnosis, treatment, and pathophysiology of social anxiety disorder, other anxiety disorders, and depression. He has been the recipient of Federal funding to conduct clinical trials establishing the efficacy of medications and combined medication-cognitive-behavioral treatments for social anxiety disorder and PTSD. He is also trained in cognitive-behavioral therapy. Dr. Schneier has also been funded by NIMH to use PET and fMRI imaging techniques to study social anxiety disorder and depression. He is author of more than 150 scholarly publications and a book for general audiences, The Hidden Face of Shyness.
Dr. Schneier also maintains a private practice in general psychiatry, including diagnostic assessment and consultations, psychopharmacology and cognitive-behavioral therapy. He combines a focus on evidence-based treatment with recognition of the need for a creative and individualized approach to the unique aspects of each person.
Undergraduate: Yale University, B.S., 1979
Medical School: Cornell Medical College, M.D., 1983
Internship: Tufts-New England Medical Center, Psychiatry, 1983 - 1984
Residency: Mt. Sinai Medical Center, Psychiatry, 1984 - 1987
Fellowship: N.Y. State Psychiatric Instiute, Clinical Research, 1987- 1990
Board Certifications: American Board of Psychiatry and Neurology
• Anxiety Disorders
• Cognitive-Behavioral Therapy
Click here for Dr. Schneier's Clinical Trials
NYS Psychiatric Institute
Room 3722 Unit/Box:69
1051 Riverside Drive
New York, NY 10032
My research interests include the integration of pharmacological and cognitive-behavioral approaches to treatment of social anxiety disorder, posttraumatic stress disorder, and depression and the application of PET and fMRI to understanding brain function in these conditions.
1. Schneier FR
: Clinical Practice: Social anxiety disorder. New England Journal of Medicine 2006;355: 1029-1036
2. Schneier FR, Pomplun M, Sy M, Hirsch J. : Neural response to eye contact and paroxetine treatment in generalized
social anxiety disorder.
. Psychiatry Research Neuroimaging 2011;194: 271-8
3. Schneier FR, Neria Y, Pavlicova M, Hembree E, Suh EJ, Amsel L, Marshall RD. : Combined Prolonged Exposure
Therapy and Paroxetine for Posttraumatic Stress Disorder Related to the World Trade Center Attacks: A Randomized Controlled Trial
. American Journal of Psychiatry 2011;169: 80-88
4. Schneier FR, Belzer K, Kishon R, Amsel L, Simpson HB: Escitalopram for persistent symptoms of generalized
anxiety disorder after CBT: A pilot study.
. Journal of Nervous and Mental Disease 2010;198: 458-461
5. Schneier FR, Foose TE, Hasin DS, Heimberg RG, Liu S-M, Grant BF, Blanco C: Social anxiety disorder and alcohol use disorder comorbidity in the National Epidemiologic Survey on Alcohol and Related Conditions.
. Psychological Medicine 2010;40: 977-88